Lataa...
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
PARP inhibitors have been proposed as a potential targeted therapy for patients with triple-negative (ER-, PR-, HER2-negative) breast cancers. However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be most beneficial. To better understand the mech...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
WILEY-VCH Verlag
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3491838/ https://ncbi.nlm.nih.gov/pubmed/22933245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201201250 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|